Literature DB >> 602258

Interplay of factors leading to adverse drug reactions in the liver, a personal viewpoint.

F Schaffner.   

Abstract

Adverse drug reactions in liver involve formation of a reactive metabolic intermediary of the drug, binding of the intermediary to macromolecules in the cell, notably proteins in the plasma membrane, immunological response to these altered proteins and attack against hepatocytes bearing these altered proteins by immune mechanisms. At each step in this complex process many factors act to enhance or depress drug metabolism, metabolite disposition, macromolecular binding, neoantigen formation, and the cell mediated and humoral immune attack. The extent and direction of each step may be dose dependent but the complexity of the overall mechanism is so immense that predictability of hepatic drug reactions is unlikely in most instances.

Entities:  

Mesh:

Year:  1977        PMID: 602258      PMCID: PMC2595561     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  32 in total

1.  Capillarization of hepatic sinusoids in man.

Authors:  F SCHAFFNER; H POPER
Journal:  Gastroenterology       Date:  1963-03       Impact factor: 22.682

2.  Lysosomal degradation of cell organelles. IV. Heterophagocytosis and acute inflammation in liver after intravenous injection of isolated liver-cell plasma membranes.

Authors:  H Glaumann; B F Trump
Journal:  Exp Mol Pathol       Date:  1976-12       Impact factor: 3.362

Review 3.  Hepatic drug reactions.

Authors:  V Perez; F Schaffner; H Popper
Journal:  Prog Liver Dis       Date:  1972

4.  Pharmacological implications of microsomal enzyme induction.

Authors:  A H Conney
Journal:  Pharmacol Rev       Date:  1967-09       Impact factor: 25.468

5.  Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.

Authors:  T B Reynolds; R L Peters; S Yamada
Journal:  N Engl J Med       Date:  1971-10-07       Impact factor: 91.245

6.  Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus.

Authors:  W E Seaman; K G Ishak; P H Plotz
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

7.  Immunochemical evidence for six forms of rat liver cytochrome P450 obtained using antibodies against purified rat liver cytochromes P450 and P448.

Authors:  P E Thomas; A Y Lu; D Ryan; S B West; J Kawalek; W Levin
Journal:  Mol Pharmacol       Date:  1976-09       Impact factor: 4.436

8.  Organ and species differences in microsomal activation of methyldopa.

Authors:  E Dybing
Journal:  Drug Metab Dispos       Date:  1976 Nov-Dec       Impact factor: 3.922

Review 9.  Immunological aspects of hepatitis B virus infection.

Authors:  T S Edgington; F V Chisari
Journal:  Am J Med Sci       Date:  1975 Sep-Oct       Impact factor: 2.378

10.  Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis.

Authors:  E Dybing; S D Nelson; J R Mitchell; H A Sasame; J R Gillette
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.